-
Signature
-
/s/ James Dillon, As Attorney-in-Fact
-
Stock symbol
-
MRNA
-
Transactions as of
-
Apr 5, 2024
-
Transactions value $
-
-$71,859
-
Form type
-
4
-
Date filed
-
4/9/2024, 04:09 PM
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
MRNA |
Common Stock |
Options Exercise |
|
+1.45K |
+33.79% |
|
5.75K |
Apr 5, 2024 |
Direct |
F1 |
| transaction |
MRNA |
Common Stock |
Sale |
-$71.9K |
-705 |
-12.25% |
$101.93 |
5.05K |
Apr 8, 2024 |
Direct |
F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
MRNA |
Restricted Stock Units |
Options Exercise |
$0 |
-1.45K |
-9.09% |
$0.00 |
14.5K |
Apr 5, 2024 |
Common Stock |
1.45K |
|
Direct |
F1, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: